SK50596A3 - Method for the preparation of quinolones-containing peroral compositions - Google Patents

Method for the preparation of quinolones-containing peroral compositions Download PDF

Info

Publication number: SK50596A3
Authority: SK; Slovakia
Prior art keywords: group; compaction; atom; mixture; tablets
Prior art date: 1993-10-21

Application number

SK505-96A

Other languages

English (en)

Slovak (sk)

Inventor

Gabriel Gousset

Philippe Riviere

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-21

Filing date

1994-10-19

Publication date

1997-02-05

1994-10-19 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1997-02-05 Publication of SK50596A3 publication Critical patent/SK50596A3/sk

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

SK505-96A 1993-10-21 1994-10-19 Method for the preparation of quinolones-containing peroral compositions SK50596A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9312550A FR2711524B1 (fr)	1993-10-21	1993-10-21	Procédé de préparation de compositions orales contenant des quinolones.
PCT/FR1994/001211 WO1995011022A1 (fr)	1993-10-21	1994-10-19	Procede de preparation de compositions orales contenant des quinolones

Publications (1)

Publication Number	Publication Date
SK50596A3 true SK50596A3 (en)	1997-02-05

Family

ID=9452072

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK505-96A SK50596A3 (en)	1993-10-21	1994-10-19	Method for the preparation of quinolones-containing peroral compositions

Country Status (30)

Country	Link
US (1)	US5840333A (cs)
EP (1)	EP0724442A1 (cs)
AT (1)	ATA905894A (cs)
AU (1)	AU7997094A (cs)
BE (1)	BE1007326A3 (cs)
CA (1)	CA2174444A1 (cs)
CH (1)	CH686555A5 (cs)
CO (1)	CO4180603A1 (cs)
CZ (1)	CZ113696A3 (cs)
DZ (1)	DZ1818A1 (cs)
EE (1)	EE9600050A (cs)
ES (1)	ES2126474B1 (cs)
FI (1)	FI961717L (cs)
FR (1)	FR2711524B1 (cs)
GB (1)	GB2297908B (cs)
GR (1)	GR1002181B (cs)
HU (1)	HUT74181A (cs)
IE (1)	IE940838A1 (cs)
IT (1)	IT1270672B (cs)
LU (1)	LU88724A1 (cs)
MA (1)	MA23331A1 (cs)
NO (1)	NO961429L (cs)
NZ (1)	NZ274874A (cs)
OA (1)	OA10282A (cs)
PL (1)	PL314005A1 (cs)
SG (1)	SG52202A1 (cs)
SK (1)	SK50596A3 (cs)
TN (1)	TNSN94110A1 (cs)
WO (2)	WO1995011023A1 (cs)
ZA (1)	ZA948175B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN186245B (cs)	1997-09-19	2001-07-14	Ranbaxy Lab Ltd
DE69934582T2 (de) *	1998-06-11	2007-10-04	Pharmacia & Upjohn Co. Llc, Kalamazoo	Delavirdin tablettenformulierung
US6342598B1 (en)	1998-11-26	2002-01-29	Bracco International B.V.	Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
JP4792032B2 (ja)	2004-08-13	2011-10-12	シェーリング−プラウ・リミテッド	抗生物質、トリアゾールおよびコルチコステロイドを含む薬学的処方物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4639458A (en) *	1985-01-22	1987-01-27	Merck & Co., Inc.	Tablet and formulation
JPH01175936A (ja) *	1987-12-28	1989-07-12	Kyorin Pharmaceut Co Ltd	６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
US4973470A (en) *	1989-06-26	1990-11-27	Warner-Lambert Company	Sustained release pharmaceutical compositions
JPH10175936A (ja) *	1996-12-17	1998-06-30	Kao Corp	新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物

1993
- 1993-10-21 FR FR9312550A patent/FR2711524B1/fr not_active Expired - Fee Related
1994
- 1994-09-15 MA MA23651A patent/MA23331A1/fr unknown
- 1994-10-18 ZA ZA948175A patent/ZA948175B/xx unknown
- 1994-10-19 AU AU79970/94A patent/AU7997094A/en not_active Abandoned
- 1994-10-19 FI FI961717A patent/FI961717L/fi unknown
- 1994-10-19 GR GR940100472A patent/GR1002181B/el unknown
- 1994-10-19 US US08/632,394 patent/US5840333A/en not_active Expired - Fee Related
- 1994-10-19 NZ NZ274874A patent/NZ274874A/en unknown
- 1994-10-19 CA CA002174444A patent/CA2174444A1/fr not_active Abandoned
- 1994-10-19 BE BE9400944A patent/BE1007326A3/fr not_active IP Right Cessation
- 1994-10-19 ES ES009550022A patent/ES2126474B1/es not_active Expired - Lifetime
- 1994-10-19 HU HU9601041A patent/HUT74181A/hu unknown
- 1994-10-19 WO PCT/FR1994/001212 patent/WO1995011023A1/fr not_active Ceased
- 1994-10-19 CZ CZ961136A patent/CZ113696A3/cs unknown
- 1994-10-19 IT ITMI942130A patent/IT1270672B/it active IP Right Grant
- 1994-10-19 EE EE9600050A patent/EE9600050A/xx unknown
- 1994-10-19 GB GB9608316A patent/GB2297908B/en not_active Expired - Fee Related
- 1994-10-19 PL PL94314005A patent/PL314005A1/xx unknown
- 1994-10-19 SG SG1996000170A patent/SG52202A1/en unknown
- 1994-10-19 AT AT0905894A patent/ATA905894A/de unknown
- 1994-10-19 SK SK505-96A patent/SK50596A3/sk unknown
- 1994-10-19 WO PCT/FR1994/001211 patent/WO1995011022A1/fr not_active Ceased
- 1994-10-19 CH CH01837/95A patent/CH686555A5/fr not_active IP Right Cessation
- 1994-10-19 DZ DZ940108A patent/DZ1818A1/fr active
- 1994-10-19 EP EP94931613A patent/EP0724442A1/fr not_active Withdrawn
- 1994-10-20 CO CO94047881A patent/CO4180603A1/es unknown
- 1994-10-20 IE IE940838A patent/IE940838A1/en not_active IP Right Cessation
- 1994-10-21 TN TNTNSN94110A patent/TNSN94110A1/fr unknown
1996
- 1996-03-14 LU LU88724A patent/LU88724A1/fr unknown
- 1996-04-11 NO NO961429A patent/NO961429L/no unknown
- 1996-04-19 OA OA60816A patent/OA10282A/fr unknown

Also Published As

Publication number	Publication date
GR1002181B (en)	1996-03-12
FI961717A7 (fi)	1996-04-19
FR2711524A1 (fr)	1995-05-05
FR2711524B1 (fr)	1995-11-24
IT1270672B (it)	1997-05-07
HU9601041D0 (en)	1996-06-28
ITMI942130A1 (it)	1996-04-19
ATA905894A (de)	2000-06-15
BE1007326A3 (fr)	1995-05-16
SG52202A1 (en)	1998-09-28
IE940838A1 (en)	1995-05-03
AU7997094A (en)	1995-05-08
TNSN94110A1 (fr)	1995-09-21
CA2174444A1 (fr)	1995-04-27
ES2126474A1 (es)	1999-03-16
PL314005A1 (en)	1996-08-05
FI961717A0 (fi)	1996-04-19
NZ274874A (en)	1997-10-24
NO961429D0 (no)	1996-04-11
LU88724A1 (fr)	1996-08-23
CZ113696A3 (en)	1996-07-17
FI961717L (fi)	1996-04-19
ITMI942130A0 (it)	1994-10-19
MA23331A1 (fr)	1995-04-01
NO961429L (no)	1996-04-11
ES2126474B1 (es)	1999-11-16
DZ1818A1 (fr)	2002-02-17
GB2297908A (en)	1996-08-21
CO4180603A1 (es)	1995-06-07
OA10282A (fr)	1997-10-07
GB9608316D0 (en)	1996-06-26
EP0724442A1 (fr)	1996-08-07
WO1995011022A1 (fr)	1995-04-27
ZA948175B (en)	1995-06-08
CH686555A5 (fr)	1996-04-30
US5840333A (en)	1998-11-24
WO1995011023A1 (fr)	1995-04-27
HUT74181A (en)	1996-11-28
EE9600050A (et)	1996-10-15
GB2297908B (en)	1997-12-10

Publication	Publication Date	Title
US7998505B2 (en)	2011-08-16	Dry granulation binders, products, and use thereof
CA2214575C (en)	1999-12-07	Paroxetine tablets and process to prepare them
CA2200754C (en)	2008-04-15	Process of making dosage units by wet granulation
US5370878A (en)	1994-12-06	Method for preparing a direct compression granulated acetaminophen composition
OA12777A (en)	2006-07-06	Formulations of atorvastatin stabilized with alkali metal additions.
EP2496261B1 (en)	2017-12-20	Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
EP0497331B1 (en)	1996-08-28	Process for the preparation of tablets or film-coated tablets
SK50596A3 (en)	1997-02-05	Method for the preparation of quinolones-containing peroral compositions
FI103179B (fi)	1999-05-14	Menetelmä muotoiltujen, puristettujen, hidastetusti vapauttavien annos teluyksiköiden valmistamiseksi
DE102008000351B4 (de)	2017-08-10	Verfahren zur Herstellung eines Ebastin enthaltenden Granulats sowie einer festen pharmazeutischen Zusammensetzung, Ebastin enthaltendes Granulat und dessen Verwendung
US20020086053A1 (en)	2002-07-04	Formulations, tablets of paroxetine and process to prepare them
KR20030070088A (ko)	2003-08-27	시탈로프람 함유 약학 조성물
US5183666A (en)	1993-02-02	Pressing not delayed release of active compound, process for its production and use of polyhydroxybutyric acid for the production of such a pressing
JP7584249B2 (ja)	2024-11-15	プラスグレルを含む混合物の混合方法及びその利用
JP2702325B2 (ja)	1998-01-21	顆粒状カルシウム組成物及びそれからなる錠剤
RU2289422C2 (ru)	2006-12-20	Фармацевтическая композиция на основе ноопепта
JPH03167122A (ja)	1991-07-19	塩酸ベラパミルを含有する固体医薬品の製法及び固体医薬品
US20060247255A1 (en)	2006-11-02	Method for preparing a stable gatifloxacin composition
HK1012285B (en)	2000-06-30	Paroxetine tablets and process to prepare them